EHS appointed to support GSK throughout 2023-2024 with transition to their new corporate identity.
In 2022 FTSE100 Pharmaceutical company GSK (LON:GSK) announced a company rebrand as it refocuses its ambition in the field of “biopharma innovation”. Behind the rebrand is London-based consultancy Wolff Olins. Their work includes an updated logo, bespoke typeface, and motion assets. The rebrand follows an announcement last year that GSK’s consumer-facing products – which include […]